{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:07Z","timestamp":1790094547392,"version":"4.0.1"},"reference-count":19,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"accepted":{"date-parts":[[2016,12,21]]},"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Rapidly progressive dementia mimicking Creutzfeldt\u2013Jakob disease (CJD) is a relatively rare presentation but a rewarding one to become familiar with, as the potential diagnoses range from the universally fatal to the completely reversible. Patients require urgent decisions about assessment and investigation and have quickly evolving needs for treatments and support, through symptom management and end-of-life care in most cases. We have based this pragmatic review on the experiences of a specialist prion referral centre in the UK, which, unsurprisingly, is strongly biased towards seeing patients with CJD. Cases eventually proven not to have prion disease might be described as \u2018CJD-mimics\u2019; being referred from UK neurologists, these are the most challenging cases. CJD in its classical presentation is very rarely mimicked; however, it is highly heterogeneous, and atypical forms can mimic virtually all common neurodegenerative syndromes. Warning features of a mimic include generalised seizures, hyponatraemia, fever, a facial movement disorder, a normal neurological examination and a modestly rapid presentation. Contrast-enhancing lesions or MRI signal hyperintensity outside the striatum, thalamus or cortex and a cerebrospinal fluid pleocytosis are key investigation pointers to a CJD mimic.<\/jats:p>","DOI":"10.1136\/practneurol-2016-001571","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T20:57:14Z","timestamp":1486069034000},"page":"113-121","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":92,"title":["CJD mimics and chameleons"],"prefix":"10.1136","volume":"17","author":[{"given":"Simon","family":"Mead","sequence":"first","affiliation":[{"name":"NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rudge","sequence":"additional","affiliation":[{"name":"NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"2025090409385128000_17.2.113.1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21430"},{"key":"2025090409385128000_17.2.113.2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2217\/nmt.13.75","article-title":"When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia","volume":"4","author":"Day","year":"2014","journal-title":"Neurodegener Dis Manag"},{"key":"2025090409385128000_17.2.113.3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/CON.0000000000000319","article-title":"Rapidly progressive dementia","volume":"22","author":"Geschwind","year":"2016","journal-title":"Continuum"},{"key":"2025090409385128000_17.2.113.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2010.235721"},{"key":"2025090409385128000_17.2.113.5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh249"},{"key":"2025090409385128000_17.2.113.6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/WAD.0b013e31819e099b","article-title":"Rapidly progressive dementia: causes found in a Greek tertiary referral center in Athens","volume":"23","author":"Papageorgiou","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2025090409385128000_17.2.113.7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.519"},{"key":"2025090409385128000_17.2.113.8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jamaneurol.2015.4885","article-title":"Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob disease","volume":"73","author":"Mead","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025090409385128000_17.2.113.9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/acn3.195","article-title":"The cognitive profile of prion disease: a prospective clinical and imaging study","volume":"2","author":"Caine","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2025090409385128000_17.2.113.10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.074856"},{"key":"2025090409385128000_17.2.113.11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12111460"},{"key":"2025090409385128000_17.2.113.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp191"},{"key":"2025090409385128000_17.2.113.13","first-page":"874","article-title":"The 14-3-3 brain protein and transmissible spongiform encephalopathy","volume":"336","author":"Zerr","year":"1997","journal-title":"N Engl J Med"},{"key":"2025090409385128000_17.2.113.14","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.033365-0"},{"key":"2025090409385128000_17.2.113.15","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMc1410732","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Zanusso","year":"2014","journal-title":"N Engl J Med"},{"key":"2025090409385128000_17.2.113.16","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","article-title":"Prospective diagnosis of sporadic CJD by the detection of abnormal PrP in patient urine","volume":"73","author":"Luk","year":"2016","journal-title":"JAMA Neurol"},{"key":"2025090409385128000_17.2.113.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.07.017"},{"key":"2025090409385128000_17.2.113.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"2025090409385128000_17.2.113.19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s13311-015-0410-6","article-title":"Antibody-mediated autoimmune encephalopathies and immunotherapies","volume":"13","author":"Gastaldi","year":"2016","journal-title":"Neurotherapeutics"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2016-001571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:38:58Z","timestamp":1757003938000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2016-001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,3,18]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1136\/practneurol-2016-001571"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2016-001571","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"value":"1474-7758","type":"print"},{"value":"1474-7766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}